IndiaTickerLatest filing: Goldline Pharmaceutical Ltd - 544759 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
ObservedCompany dossier
Goldline Pharmaceutical
BSE:GLPL · ISIN INE1CLW01015
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Goldline Pharmaceutical
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 57.29% and public 42.71% as of 17 May 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Goldline Pharmaceutical Ltd - 544759 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Goldline Pharmaceutical Ltd - 544759 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Observed
Source filing Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
BSE · exchange filing
Observed
Source filing Goldline Pharmaceutical Ltd - 544759 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →17 May 2026
- Promoter group
- 57.29%
- Public
- 42.71%
- Employee trust
- N/A
Observed BSE shareholding XBRL